Patents/Inventors

Matthew J. Bernett

Monrovia, CAUS15 patents

14 Patents

US125595722026
Compositions and Methods for Treating Ige-mediated Disorders
Xencor, Inc.
0 cites
US125094952025
LAG-3 Targeted Heterodimeric Fusion Proteins Containing IL-15/IL-15RA Fc-fusion Proteins and LAG-3 Antigen Binding Domains
Xencor, Inc.
0 cites
US124863112025
Ctla4-ig Immunoadhesins
Xencor, Inc.
0 cites
US124484232025
Targeted Heterodimeric Fc Fusion Proteins Containing NKG2D Antigen Binding Domains
Xencor, Inc.
0 cites
US123982072025
Heterodimeric Antibodies That Bind CD3 and CLDN6
Xencor, Inc.
0 cites
US121395252024
Targeted Heterodimeric Fc Fusion Proteins Containing IL-15 Il-15alpha and Antigen Binding Domains
Xencor, Inc.
0 cites
US119458802024
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US118590112024
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US118590122024
Heterodimeric Antibodies That Bind CD3 and GPC3
Xencor, Inc.
0 cites
US117391442023
Heterodimeric Antibodies That Bind CD3 and CLDN6
Xencor, Inc.
0 cites
US116739722023
Heterodimeric Antibodies That Bind CD3 and Tumor Antigens
Xencor, Inc.
0 cites
US116187762023
Targeted Heterodimeric Fc Fusion Proteins Containing IL-15/IL-15RA and NKG2D Antigen Binding Domains
Xencor, Inc.
0 cites
US116187882023
Optimized Antibodies That Target CD19
XENCOR, Inc.
0 cites
US115660802023
Compositions and Methods for Treating Ige-mediated Disorders
Xencor, Inc.
0 cites